Piper Sandler keeps Axsome Therapeutics price target at $258
Piper Sandler maintained a $258.00 per-share price target for Axsome Therapeutics, per Benzinga (TradingView News).
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Piper Sandler maintained a $258.00 per-share price target for Axsome Therapeutics, per Benzinga (TradingView News).